Search Medical Condition
Please enter condition
Please choose location

Fort Mitchell, Kentucky Clinical Trials

A listing of Fort Mitchell, Kentucky clinical trials actively recruiting patient volunteers.

RESULTS

Found (446) clinical trials

Vismodegib and FAK Inhibitor GSK2256098 in Treating Patients With Progressive Meningiomas

PRIMARY OBJECTIVES: I. To determine the activity of a smoothened, frizzled class receptor (SMO) and PTCH1 inhibitor in patients with meningiomas harboring SMO mutations as measured by 6-month progression free survival (PFS) and response rate. II. To determine the activity of a FAK inhibitor in patients with meningiomas harboring neurofibromin ...

Phase

1.19 miles

Learn More »

Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease

The drug being tested in this study is called vedolizumab subcutaneous (vedolizumab SC). Vedolizumab SC is being tested to treat people who have moderate to severely active Crohn's disease (CD). This study will look at clinical remission in participants with CD who receive vedolizumab SC maintenance therapy after having achieved ...

Phase

1.19 miles

Learn More »

Vedolizumab Subcutaneous Long-Term Open-Label Extension Study

The drug being tested in this study is called vedolizumab subcutaneous (vedolizumab SC). Vedolizumab SC is being tested to assess its long-term safety and effectiveness in treating participants with UC or CD. This study will look at the long-term side effects and response/remission of UC and CD in participants who ...

Phase

1.19 miles

Learn More »

The purpose of this research study is to compare the long-term joint safety and efficacy (pain relief) of the investigational study drug, tanezumab, compared to non-steroidal anti-inflammatory drugs (NSAIDs) in subjects with osteoarthritis of the hips or knees. Non-steroidal anti-inflammatory drugs (naproxen, celecoxib, or diclofenac) are drugs that are approved ...

Phase

1.19 miles

Learn More »

The purpose of this research study is to compare the effects of the investigational study drug, tanezumab, with another drug called tramadol (also called Tradorec XL®, prolonged release tablets) and a placebo to find out which is better for treating chronic low back pain. Tramadol is a drug that is ...

Phase

1.19 miles

Learn More »

The purpose of this research study is to evaluate an investigational product called rexlemestrocel-L.The study sponsor Mesoblast Ltd. makes rexlemestrocel-L from a certain type of stem cell. Stem cells are unspecialized cells that can turn into various specialized cell types such as blood or vascular cells, muscle, cartilage, or bone. ...

Phase N/A

1.19 miles

Learn More »

Multicenter Post-Approval Study Of The Glaukos iStent Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery

The purpose of this study is to assess the long-term safety of the Glaukos® iStent® Trabecular Micro-Bypass Stent Model GTS100 in conjunction with cataract surgery compared to cataract surgery only, in subjects with mild to moderate open-angle glaucoma.

Phase

1.19 miles

Learn More »

Octagam 5% Versus Comparator Post Marketing Trial

This Post Marketing Study is a prospective, 2-armed, multicenter, non-interventional study. Patients will either be administered the brand of IGIV therapy ordered by their prescribing physician, or for patients issued unspecified or generic prescriptions of IGIV therapy, octagam® 5% or another brand of IGIV therapy will be provided by the ...

Phase N/A

1.19 miles

Learn More »

Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer.

Patients will be randomised in 1:1 ratio to either olaparib or placebo. Randomisation will be stratified by Hormone receptor status (ER and/or PgR positive/HER2 negative versus TNBC), prior neoadjuvant versus adjuvant chemotherapy and prior platinum use for breast cancer. Randomised patients will receive study treatment for up to a maximum ...

Phase

1.19 miles

Learn More »